To describe the effect of the combination treatments with Dasatinib/Rapamycin or Dasatinib/Torin-2 we calculate the Combination Index (CI) applying the Chou-Talalay-Method 34 as followed:

The calculations were done with the software CalcuSyn. We used normalized viability values determined by MTT assays as described above. For the calculation the viability values were converted to the “Fraction Affected” (FA) 35 as followed:

For the calculation, a constant dilution factor for both drugs is necessary. To test different concentration ranges we used various dilution factors (such as 1.5, 2.0 or 2.5). Three replicates were performed for each experiment. For calculation of the CI we used the results of at least two independent experiments.

The calculation of the Dose Reduction Factor (DRF) was done as followed:

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.